PROF vs TMCI: stock comparison and AI forecast
Profound Medical Corp. (PROF) and Treace Medical Concepts, Inc. (TMCI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PROF Profound Medical Corp.
- Price
- $7.21 +0.7% · 6M
- Market Cap
- $263M
- P/E Ratio
- 7.7x
- Size
- small-cap
- AI Forecast
TMCI Treace Medical Concepts, Inc.
- Market Cap
- $262M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- PROF and TMCI have similar market capitalizations ($263M and $262M).
- TMCI carries 1.91 times debt per unit of equity, against 0.37 times for PROF.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PROF | TMCI |
|---|---|---|
| Market Cap | $263M | $262M |
| P/E Ratio | 7.67x | – |
| P/B Ratio | 6.20x | 4.25x |
| EPS | $0.94 | $-0.86 |
| Book Value/Share | $1.16 | $0.95 |
| Revenue/Share | $0.65 | $3.13 |
| FCF/Share | – | $-0.29 |
Profitability & Margins
| Metric | PROF | TMCI |
|---|---|---|
| ROE | – | -90.5% |
| ROA | – | -31.1% |
| ROIC | -74.4% | -37.2% |
| Gross Margin | 73.9% | 79.5% |
| Operating Margin | -145.1% | -24.4% |
| Net Margin | – | -27.4% |
| EBT Margin | -137.1% | -24.4% |
| Tax Rate | -0.3% | – |
Financial Health
| Metric | PROF | TMCI |
|---|---|---|
| Current Ratio | 4.54x | 2.58x |
| Quick Ratio | 3.70x | 1.66x |
| D/E Ratio | 0.37x | 1.91x |
| Financial Leverage | 1.37x | 2.91x |
| Interest Coverage | -97.8x | -7.3x |
| Working Capital | $43M | $73M |
Cash Flow
| Metric | PROF | TMCI |
|---|---|---|
| Operating Cash Flow | -$31M | -$9M |
| Free Cash Flow | – | -$19M |
| Capital Spending | – | -$10M |
| FCF/Sales | – | -9.1% |
| CapEx/Sales | – | 4.8% |
Operational Efficiency
| Metric | PROF | TMCI |
|---|---|---|
| Asset Turnover | 0.41x | 1.13x |
| Receivables Turnover | – | 6.7x |
| Inventory Turnover | 0.6x | 1.0x |
| Fixed Assets Turnover | 55.0x | 6.2x |
| Days Sales Outstanding | – | 54 days |
| Days Inventory | 605 days | 371 days |
| Payables Period | 62 days | 125 days |
| Cash Conversion Cycle | – | 300 days |
Income Statement
| Metric | PROF | TMCI |
|---|---|---|
| Total Revenue | $24M | $203M |
| Operating Income | -$34M | -$50M |
| Net Income | – | -$56M |
| R&D Expense | $21M | $18M |
| SG&A Expense | $31M | $247M |
| Cost of Goods Sold | $6M | $42M |
Dividend & Shareholder Information
| Metric | PROF | TMCI |
|---|---|---|
| Shares Outstanding | 37M | 65M |
| EPS Growth | 74.1% | – |
PROF vs TMCI: stock comparison and AI forecast
Which is bigger, PROF or TMCI?
PROF and TMCI have similar market capitalizations ($263M and $262M).
Which one does Intratio's AI model rank higher, PROF or TMCI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.